Loading clinical trials...
Loading clinical trials...
The objective of the study is to investigate the safety, efficacy and clinical utility of the Occlutech PDA device for closure of patent ductus arteriosus of all types.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Occlutech International AB
NCT06658496 · Patent Ductus Arteriosus, Congenital Heart Disease
NCT07143201 · Patent Ductus Arteriosus, Preterm
NCT06298344 · Congenital Heart Disease, Thiamine Deficiency, and more
NCT07248761 · Shock, Preterm Birth Complication, and more
NCT03456336 · Infant, Premature, Patent Ductus Arteriosus, and more
IJN National Heart Institute
Kuala Lumpur
Pediatric Hospital no 2
Hochiminh City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions